High Dose Vitamin D and MS Relapse: New Phase 3 Data

Data from a phase 3 trial suggest high-dose vitamin D does not prevent relapse in patients with RRMS. However, at least one expert suggests the study's exclusion criteria may have been too broad.

Related Keywords

Maryland ,United States ,Baltimore ,Boston ,Massachusetts ,Johns Hopkins University ,Francesw Johnson ,Alberto Ascherio ,Ellen Mowry ,Johns Hopkins University School Of Medicine , ,Johns Hopkins University School ,Medscape Medical ,Relapse Risk ,Kurtzke Expanded Disability Status ,Medscape Medical News ,Public Health ,Multiple Sclerosis Ms ,Multiple Sclerosis ,Us ,Vitamins ,Multiple Sclerosis Progression ,Als Progression ,Multiple Sclerosis Treatment ,Als Treatment ,Reatment Of Multiple Sclerosis ,Reatment Of Ms ,Multiple Sclerosis Imaging ,S Imaging ,Maging In Multiple Sclerosis ,Maging In Ms ,Maging Studies In Multiple Sclerosis ,Maging Studies In Ms ,Vitamind Deficiency ,Ms Lesion ,Ultiple Sclerosis Lesio ,